## KEYS: Keysight Technologies, Inc. - XLK: Technology

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 9.9% in upper entry zone (4.0-10.0%), top 4% cross-sectional ranking. Short-term MRS_5 (2.1%) confirms momentum alignment. Strong momentum (+2.9% 5-day acceleration). Outperforming sector by 9.6%. Caution: overbought RSI (76).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($198.83)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 8, Bearish: 0)

**1. Have Insiders Sold Keysight Technologies Shares Recently?**
- Source: Simply Wall Street | 20251205T120918 | Somewhat-Bearish | Relevance: 100%
- Keysight Technologies' Non-Executive Chair recently sold a substantial US$5.9m worth of stock, decreasing his holding by 13%. While insider selling below the current price can be discouraging, the company is profitable and growing, and insiders still own 0.6% of the company, valued at US$198m. This article examines the implications of recent insider transactions for Keysight Technologies shareholders.

**2. Have Insiders Sold Keysight Technologies Shares Recently?**
- Source: Simply Wall Street | 20251205T120834 | Somewhat-Bearish | Relevance: 100%
- Keysight Technologies Inc. (NYSE:KEYS) recently saw its Non-Executive Chair, Ronald Nersesian, sell US$5.9m worth of stock at US$197 per share, reducing his holding by 13%. This sale represents the largest insider disposal in the past year, occurring at a price below the current market value of US$209. Although insider selling can be a weak negative signal, the company's profitability and growth temper concerns, but a "warning sign" suggests caution for potential investors.

**3. Keysight Introduces New Handheld Analyzer Enabling 120-MHz IQ Streaming for Gap-Free Signal Capture**
- Source: 01net | 20251204T190754 | Bullish | Relevance: 100%
- Keysight Technologies has introduced the N99xxD-Series FieldFox Handheld Analyzer, which offers 120 MHz gap-free IQ streaming, high-speed data transfer, and seamless field-to-lab integration. This new series is designed to address the increasing complexity of RF environments by providing advanced capabilities for signal analysis, interference detection, and wideband signal characterization. The analyzer also integrates AI capabilities for faster and more accurate classification of wireless standards like LTE, 5G NR, Wi-Fi, and Bluetooth, enhancing spectrum management and troubleshooting.

**4. Keysight (NYSE: KEYS) launches FieldFox D-Series for wideband RF signal analysis**
- Source: Stock Titan | 20251204T161004 | Bullish | Relevance: 100%
- Keysight Technologies Inc. (NYSE: KEYS) has launched its new N99xxD-Series FieldFox Handheld Analyzer, enabling 120 MHz gap-free IQ streaming and high-speed data transfer for advanced wideband RF signal analysis. This series combines ruggedness with precision, offering features like AI-powered spectrum management and a touchscreen interface. The FieldFox D-Series aims to provide engineers with enhanced visibility into complex RF environments, accelerating troubleshooting and optimizing system performance.

**5. KEYS: AI-driven Wireline growth, margin expansion, and disciplined M&A fuel Keysight's momentum**
- Source: TradingView | 20251204T152227 | Bullish | Relevance: 100%
- Keysight's competitive advantage stems from trust, client integration, and a first-to-market approach. Recent growth is fueled by AI demand in Wireline, strong financial discipline, and strategic M&A, with further margin expansion expected. This information is based on an AI-generated summary of Keysight Technologies Inc.'s Citi Annual Global Healthcare Conference audio transcript from December 4, 2025.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 10, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-26 | Baird | $210 | $205 | +2% |
| 2025-11-25 | Jefferies | $195 | $180 | +8% |
| 2025-11-25 | Citigroup | $220 | $215 | +2% |
| 2025-11-25 | UBS | $230 | $220 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-26 | Baird | main | Outperform |
| 2025-11-25 | Jefferies | main | Hold |
| 2025-11-25 | Citigroup | main | Buy |
| 2025-11-25 | UBS | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 12 ($0.00M) |
| Sells | 50 ($16.91M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 50.5% |
| Smart Money | **NEUTRAL** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (+0.5%)
- Price (T.Rowe) Assoc: 10.1% (-8.6%)
- Blackrock Inc.: 9.8% (+1.9%)
- State Street Corpora: 4.7% (+0.2%)
- Geode Capital Manage: 3.0% (+12.7%)

### Key Risks

1. Heavy insider selling: $17M sold (50 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 10 raises (avg +9%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +2.9% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.56 elevated, pricing in significant growth expectations. Quality metrics strong (margin 16%). Balance sheet: strong liquidity (2.4x). Analyst sentiment positive (10 raises, avg +9%). Insider selling cluster ($16.9M in 90 days), potential headwind.

| Metric | Value |
|--------|-------|
| Market Cap | $35.4B |
| Beta | 1.20 |
| 52W Range | $121.43 - $214.58 |
| Short Interest | 2.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.56 |
| Forward P/E | 22.7 |
| Current P/E | 26.0 |
| YoY Growth | 14.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 7.0% to 9.9% (+2.9% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 95th percentile. MRS_5 at 2.1% confirms short-term momentum alignment. AM_20 at 12.3% shows strong absolute momentum above own 20MA. Outperforming sector by 9.6pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (2.84), confirming momentum. RSI overbought at 76, risk of mean reversion. OFD pattern: +SUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 9.87% (CS: 96) | Strong |
| RSI_14 | 76.3 | Overbought |
| MACD Histogram | 2.84 | Bullish |
| vs SMA20 | 1.123x | Above |
| vs SMA50 | 1.184x | Above |
| vs SMA200 | 1.287x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $210.49
- **Stop Loss:** $198.83 (5.5% risk)
- **Target:** $227.98 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 85
- **Position Value:** $17,891.65
- **Portfolio %:** 17.89%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-24 (Est: $1.99)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $1.83 | $1.91 | +4.2% |
| 2025Q3 | $1.67 | $1.72 | +2.9% |
| 2025Q2 | $1.65 | $1.70 | +3.3% |
| 2025Q1 | $1.69 | $1.82 | +7.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*